Encapsulation of selenium in chitosan nanoparticles improves selenium availability and protects cells from selenium-induced DNA damage response

Journal of Nutritional Biochemistry

Volumn 22, Issue 12, 2011, Pages 1137-1142

  Zhang, Shu ^a   Luo, Yangchao ^a   Zeng, Huawei ^b   Wang, Qin ^a   Tian, Fei ^a   Song, Jiuzhou ^a   Cheng, Wen Hsing ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Cancer; Chitosan; DNA damage; Nanoparticles; Selenium

Indexed keywords

CHITOSAN; METHYLSELENINIC ACID; POLYPHOSPHATE; SELENIUM DERIVATIVE; SODIUM SELENITE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL LEVEL; CELL PROTECTION; CELLULAR STRESS RESPONSE; CHEMICAL ANALYSIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEACETYLATION; DNA DAMAGE; EXPOSURE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG FIBROBLAST; MOLECULAR WEIGHT; NANOENCAPSULATION; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS;

APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHITOSAN; DNA DAMAGE; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HCT116 CELLS; HUMANS; NANOPARTICLES; ORGANOSELENIUM COMPOUNDS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SELENIUM; SODIUM SELENITE; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 80455172362     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.09.014     Document Type: Article

References (28)

1. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301:39-51.
2. Clark L.C., Combs G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996, 276:1957-1963.
3. Wang L., Bonorden M.J., Li G.X., Lee H.J., Hu H., Zhang Y., et al. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev Res (Phila Pa) 2009, 2:484-495.
4. Finley J.W. Reduction of cancer risk by consumption of selenium-enriched plants: enrichment of broccoli with selenium increases the anticarcinogenic properties of broccoli. J Med Food 2003, 6:19-26.
5. Rayman M.P., Combs G.F., Waters D.J. Selenium and vitamin E supplementation for cancer prevention. JAMA 2009, 301:1876.
6. Hatfield D.L., Yoo M.H., Carlson B.A., Gladyshev V.N. Selenoproteins that function in cancer prevention and promotion. Biochim Biophys Acta 2009, 1790:1541-1545.
7. Zeng H., Wu M., Botnen J.H. Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes. J Nutr 2009, 139:1613-1618.
8. Zhang S., Rocourt C., Cheng W.H. Selenoproteins and the aging brain. Mech Ageing Dev 2010, 131:253-260.
9. Lu J., Jiang C., Kaeck M., Ganther H., Vadhanavikit S., Ip C., et al. Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol 1995, 50:213-219.
10. Spallholz J.E., Shriver B.J., Reid T.W. Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of l-selenomethionine and l-Se-methylselenocysteine. Nutr Cancer 2001, 40:34-41.
11. Stewart M.S., Spallholz J.E., Neldner K.H., Pence B.C. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 1999, 26:42-48.
12. Shen C.L., Song W., Pence B.C. Interactions of selenium compounds with other antioxidants in DNA damage and apoptosis in human normal keratinocytes. Cancer Epidemiol Biomarkers Prev 2001, 10:385-390.
13. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
14. Wu M., Kang M.M., Schoene N.W., Cheng W.H. Selenium compounds activate early barriers of tumorigenesis. J Biol Chem 2010, 285:12055-12062.
15. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003, 3:155-168.
16. Wang S.L., Yao H.H., Guo L.L., Dong L., Li S.G., Gu Y.P., et al. Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA. Cancer Genet Cytogenet 2009, 190:8-14.
17. Liu A., Song W., Cao D., Liu X., Jia Y. Growth inhibition and apoptosis of human leukemia K562 cells induced by seleno-short-chain chitosan. Methods Find Exp Clin Pharmacol 2008, 30:181-186.
18. Luo Y., Zhang B., Cheng W.H., Wang Q. Preparation, characterization and evaluation of selenite-loaded chitosan/TPP nanoparticles with or without zein coating. Carbohydrate Polymer 2010, 82:942-951.
19. Ip C., Hayes C., Budnick R.M., Ganther H.E. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res 1991, 51:595-600.
20. Cheng W.H., von Kobbe C., Opresko P.L., Arthur L.M., Komatsu K., Seidman M.M., et al. Linkage between Werner syndrome protein and the Mre11 complex via Nbs1. J Biol Chem 2004, 279:21169-21176.
21. Zeng H., Botnen J.H. Copper may interact with selenite extracellularly in cultured HT-29 cells. J Nutr Biochem 2004, 15:179-184.
22. Qi Y, Schoene NW, Lartey F, Cheng WH Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells. J Biol Chem 2010, 285:33010-33017.
23. Adams D.J. The impact of tumor physiology on camptothecin-based drug development. Curr Med Chem Anticancer Agents 2005, 5:1-13.
24. Goulet A.C., Chigbrow M., Frisk P., Nelson M.A. Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells. Carcinogenesis 2005, 26:109-117.
25. Diplock A.T. Indexes of selenium status in human populations. Am J Clin Nutr 1993, 57:256S-258S.
26. IP C. Lessons from basic research in selenium and cancer prevention. J Nutr 1998, 128:1845-1854.
27. Ganther H.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 1999, 20:1657-1666.
28. Sinha V.R., Singla A.K., Wadlhawan S., Kaushik R., Kumria R. Chitosan microspheres as a potential carrier for drugs. Int J Pharmaceutics 2004, 274:1-33.